Meperidine (Demerol) Market Size to Reach $563.7 Million, Globally, by 2032 at 1.5% CAGR: Coherent Market Insights [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
is estimated to grow from US$ 507.9 Million in 2025 and is forecast to reach a value of US$ 563.7 Million by 2032 at a CAGR of 1.5% between 2025 and 2032. Request a Sample of the US Tariff Impact Analysis Report: https://www.coherentmarketinsights.com/insight/request-sample/3816 Global Meperidine (Demerol) Market Key Takeaways The global meperidine (demerol) market size is anticipated to expand from USD 507.9 Mn in 2025 to USD 563.7 Mn by 2032. Global sales of meperidine (Demerol) will likely increase at a CAGR of 1.5% throughout the forecast period. By form, tablets segment is projected to account for around USD 284.42 million in 2025. This can be attributed to patients' preference for meperidine (Demerol) tablets, owing to their convenience, longer shelf life, and ease of storage. Based on application, anesthesia segment is set to dominate the industry, accounting for a prominent meperidine (Demerol) market share in 2025. In terms of distribution channel, retail pharmaci
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Pfizer (NYSE:PFE) had its price target lowered by analysts at Bank of America Corporation from $29.00 to $28.00. They now have a "neutral" rating on the stock.MarketBeat
- Pfizer declares $0.43 dividend [Seeking Alpha]Seeking Alpha
- Pfizer Declares First-Quarter 2026 DividendBusiness Wire
- Pfizer (NYSE:PFE) was given a new $28.00 price target on by analysts at Morgan Stanley.MarketBeat
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website